l carnitine precursor The system and cancer metabolic plasticity DL-Carnitine | C7H15NO3 | CID

doi: 10.3390/antiox9090867

10.1016/j.apt.2022.103839 Summary Keywords inhalation, dry-powder nano formulation, lung diseases, nano medicine, bioavailability Citation Naureen F, Shah Y, Rehman M, Chaubey P, Nair AK, Khan J, Abdullah, Shafique M, Shah KU and Ahmad B (2024) Inhalable dry powder nano-formulations: advancing lung disease therapy-a review

The wet weight of each sample was immediately measured by an electronic balance, following which the brains were dried at 100C for 24 h to obtain the dry weight

For Laboratory and Research Purposes Only Not intended for human consumption or therapeutic use

The tradeoff is that excess amounts leave the body in urine within hours to days